PLXNA2 and breast cancer: When cultures were co-treated with 90-μM 9-me-BC and the OCT inhibition dysprocynium 24 (D24), the anti-proliferative effects of 9-me-BC were inhibited significantly in a concentration-dependent manner (Fig. 2g).